기준

Regulatory clarity is emerging as a critical catalyst for the global gene therapy sector, with recent developments signaling reduced uncertainty around FDA oversight and renewed momentum for innovative biotech firms. As major pharmaceutical companies redirect substantial investments toward next-generation modalities, the convergence of policy evolution and scientific advancement is creating a more predictable environment for … Read more